| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | EP1197218B1 Algae protein polysaccharide extraction and use thereof |
| 04/27/2011 | EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 04/27/2011 | CN201806327U Constitution health preserving mattress |
| 04/27/2011 | CN1993346B Thiophene compound |
| 04/27/2011 | CN1893925B In vivo targeting of dendritic cells |
| 04/27/2011 | CN1795027B Composition comprising lactobacilli or bifidobacteria and use thereof |
| 04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
| 04/27/2011 | CN102036979A Inhibitors of IKK-beta serine-theronine protein kinase |
| 04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
| 04/27/2011 | CN102036961A Pyridines and pyrazines as inhibitors of PI3K |
| 04/27/2011 | CN102036714A Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid |
| 04/27/2011 | CN102036683A Cytotoxic composition |
| 04/27/2011 | CN102036673A Preventative and/or therapeutic agent against atopic dermatitis |
| 04/27/2011 | CN102031244A Recombinant mesenchymal stem cell and preparation method and application thereof |
| 04/27/2011 | CN102031216A Health wine for nourishing kidney |
| 04/27/2011 | CN102030828A CTLA4-Ig fusion protein mutants with high affinity |
| 04/27/2011 | CN102030822A New human cell factor VSTM1-v2 and application thereof |
| 04/27/2011 | CN102030799A Cycloastragenol-6-O-beta-D glucoside monohydrate and crystal thereof |
| 04/27/2011 | CN102030771A Compound used as transient receptor potential vanilloid (TRPV1) blocker, medicinal composition and pharmaceutical application thereof |
| 04/27/2011 | CN102028932A Application of whey protein peptide in preparation of drugs and health food for enhancing immunity |
| 04/27/2011 | CN102028849A Chinese medicinal composition and preparation method thereof |
| 04/27/2011 | CN102028829A Qi and middle tonifying Chinese medicinal composition and preparation method thereof |
| 04/27/2011 | CN102028812A Chinese medicinal preparation for treating allergic rhinitis, allergic asthma and urticaria and preparation method thereof |
| 04/27/2011 | CN102028775A Medicament or health-care food for preventing and treating chloasma and regulating immunologic function |
| 04/27/2011 | CN102028774A Antiallergic raspberry composite product and preparation method thereof |
| 04/27/2011 | CN102028767A Traditional Chinese medicine for treating dermatitis and preparation method thereof |
| 04/27/2011 | CN102028757A Processing method of mulberry composite extract |
| 04/27/2011 | CN102028754A Method for rapidly preparing total lignans and total saponins from schisandra chinensis |
| 04/27/2011 | CN102028725A Traditional Chinese medicine composition, extract, preparation method and application thereof |
| 04/27/2011 | CN102028724A Method for preparing total flavone extracts from roundpod jute leaves |
| 04/27/2011 | CN102028656A Cetirizine dihydrochloride spray |
| 04/27/2011 | CN101744866B Traditional Chinese medicine composition for preventing and treating culture diseases of livestock and poultry, preparation method and application thereof |
| 04/27/2011 | CN101530432B Method for producing degreased concentrated solution of tussah male moth |
| 04/27/2011 | CN101391061B Novel antibiotic substitute |
| 04/27/2011 | CN101370805B Novel pyridine derivatives |
| 04/27/2011 | CN101250528B Domestic pig proliferation inducing ligand cDNA as well as clone method and recombinant uses thereof |
| 04/27/2011 | CN101247800B Anti-allergic agent |
| 04/27/2011 | CN101235038B Use of glycyrol in preparing immunity inhibitor |
| 04/27/2011 | CN101219985B N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 04/27/2011 | CN101130057B Long-acting implantation agent of pentapeptide for thymus gland and method of producing the same |
| 04/27/2011 | CN101081299B Yelk immune globulin products for preventing and treating bainite cryptosporidiosis and application thereof |
| 04/27/2011 | CN101006846B Anti-stress nutrition additives for poultry and its preparation method |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7932375 Kits for detecting rank nucleic acids |
| 04/26/2011 | US7932367 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
| 04/26/2011 | US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 04/26/2011 | US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 04/26/2011 | US7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group |
| 04/26/2011 | US7931895 Monoclonal antibodies with enhanced ADCC function |
| 04/26/2011 | US7931640 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 04/26/2011 | CA2491506C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2465103C Use of a prostaglandin derivative as an anti-pruritic agent |
| 04/26/2011 | CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2423628C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2416572C Bispecific antibody for target cell-specific stimulation of the apo-1 cell surface receptor |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2386023C Mucosal dtpa vaccines |
| 04/26/2011 | CA2341358C Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/26/2011 | CA2309602C Methods and compositions for enhancing immune response and for the production of in vitro mabs |
| 04/26/2011 | CA2215394C Il-17 receptor |
| 04/21/2011 | WO2011047384A2 Methods of inhibiting ire1 |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047031A2 Eliciting immune responses using recombinant mva viruses expressing hiv env, gag and pol anitgens |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011046916A1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/21/2011 | WO2011046200A1 Antiinflammatory agent comprising differentiation-inducing factor or analog thereof |
| 04/21/2011 | WO2011045702A1 Pyrrolo[2,3-d] pyrimidine compounds |
| 04/21/2011 | WO2011045594A1 Novel macrocycles and methods for their production |
| 04/21/2011 | WO2011045593A1 Novel macrocyles and methods for their production |
| 04/21/2011 | WO2011024110A3 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders |
| 04/21/2011 | WO2011018080A3 Composition having strains of lactobacillus fermentum |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2010141584A3 Antagonism of human formyl peptide receptor for treatment of disease |
| 04/21/2011 | WO2010135452A3 Pyrazinamide for the treatment of leishmaniases |
| 04/21/2011 | WO2008114149A3 Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains |
| 04/21/2011 | WO2008099284A3 Hiv combination vaccine and prime boost method |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092585 Immunomodulatory pharmaceutical composition and a process for preparation thereof |
| 04/21/2011 | US20110092584 Therapeutic use of quinonoid derivatives of cannabinoids |
| 04/21/2011 | US20110092573 Modification of myd88 splicing using modified oligonucleotides |
| 04/21/2011 | US20110092567 Cannabinoid 2 (Cb2) Receptor Gene Promoter and Unique RNA Transcripts in B Cells and Methods of Use |
| 04/21/2011 | US20110092561 Benzoisoindole derivatives for the treatment of pain |
| 04/21/2011 | US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092506 Trisubstituted amine compound |
| 04/21/2011 | US20110092505 Organic compounds |
| 04/21/2011 | US20110092490 Pyrimidines, triazines and their use as pharmaceutical agents |
| 04/21/2011 | US20110092485 Substituted benzoazepines as toll-like receptor modulators |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092471 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 04/21/2011 | US20110092462 Use of high-dose oxazaphosphorine drugs for treating immune disorders |